A non-interventional research study of the alterations in the microbiome in inflammatory skin disease (Trial Not Registered)

This study aims to investigate immune reactions that can be involved in atopic dermatitis (eczema). It will do this by examining the composition and differences in the microorganisms, gene expression (regulated processes that allow a cell to respond to its changing environment) and lipids/metabolites (small proteins, sugars or fats produced by cells) of people with eczema vs. people without. This will potentially support more personalised and effective treatments for people with eczema and ultimately improve patient care.

Trial phase

Other

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Prof Johannes S Kern

Key inclusion data

>18 years of age, diagnosed with or without atopic dermatitis (eczema); No history of blood clotting disorders.